Tumor angiogenesis and its clinical significance in pediatric malignant liver tumor

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 5

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

421

HTML

1786

Figures (1-2)

215

Tables (1-1)

212

Sum=2634

Feb 7, 2005 (publication date) through Nov 18, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Feb 7, 2005; 11(5): 741-743
Published online Feb 7, 2005. doi: 10.3748/wjg.v11.i5.741

Table 1 VEGF expression and MVD count in each group (mean±SD).

Groups	VEGF	MVD
Pediatric malignant liver tumor group (n = 14)	0.4971±0.14^a	33.66±12.24^a
Pediatric HCC group (n = 7)	0.5665±0.10^b	36.94±9.28^a
Pediatric non-HCC group (n = 7)	0.4276±0.15^c	30.37±14.61
Adult HCC group (n = 12)	0.4027±0.03	26.52±4.38

^aP<0.05,

^bP<0.01 vs adult HCC group;

^cP<0.05 vs pediatric HCC group.

Citation: Sun XY, Wu ZD, Liao XF, Yuan JY. Tumor angiogenesis and its clinical significance in pediatric malignant liver tumor. World J Gastroenterol 2005; 11(5): 741-743
URL: https://www.wjgnet.com/1007-9327/full/v11/i5/741.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i5.741